IFX-301 Investigational antibody program targeting APRIL for IgA nephropathy, listed in the company’s preclinical efficacy-stage pipeline.
Visit productCosigns Received
Be the first Cosign
Put your name behind IFX-301.
Add it to your Products I use list and share why you use it.